- Home
- ASTI vs KZR Comparison
ASTI vs KZR Comparison
Compare ASTI & KZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ASTI | KZR |
|---|---|---|
| Founded | 2005 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 46.8M | 47.1M |
| IPO Year | 2014 | 2018 |
Fundamental Metrics
Financial Performance| Metric | ASTI | KZR |
|---|---|---|
| Price | $4.57 | $6.53 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | ★ 809.8K | 25.2K |
| Earning Date | 05-13-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 70.23 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $10,398,149.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 163.25 | N/A |
| 52 Week Low | $1.17 | $3.53 |
| 52 Week High | $9.87 | $7.45 |
Technical Indicators
Market Signals| Indicator | ASTI | KZR |
|---|---|---|
| Relative Strength Index (RSI) | 39.99 | 44.06 |
| Support Level | $4.27 | $6.06 |
| Resistance Level | $7.10 | $7.35 |
| Average True Range (ATR) | 0.60 | 0.25 |
| MACD | -0.15 | -0.09 |
| Stochastic Oscillator | 14.20 | 20.00 |
Price Performance
Historical ComparisonAbout ASTI Ascent Solar Technologies Inc.
Ascent Solar Technologies Inc is engaged in the manufacturing, and selling of photovoltaic products (PV) solar modules that are flexible, durable, and possess attractive power-to-weight and power-to-area performance. The company is integrating its PV products into scalable and high-value markets such as agrivoltaics, aerospace, satellites, near-earth orbiting vehicles, and fixed-wing unmanned aerial vehicles (UAV). Ascent is also working to expand its portable solar chargers, such as the XD-12. The company markets and sells its products through OEMs, system integrators, distributors, retailers, and e-commerce companies.
About KZR Kezar Life Sciences Inc.
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.